From the magazine

In more than four years’ experience with cannabis legalization in Canada, one thing has become patently clear—Canadians have bought into (and are buying lots of) cannabis.

Key drug interactions, safety issues, and how to approach NHP use by your patients.

Nov. 30, 2022. That was the day ChatGPT from OpenAI launched—and there was something stunning about what it seemed to do.

For years, international medical graduates have hoped for a less circuitous route to becoming a physician in Canada, and provincial medical regulators are finally making wishes come true.

Dr. Ted Jablonski offers up a prescription … for you!

A self-help guide for getting through your work days —and finding growth along the way.

Investors prone to motion sickness were likely queasy throughout 2022. And so far, 2023 isn't looking too gentle on the portfolio either.

More medical learners are requesting accommodations such as more time on tests and no overnight call.

In our first issue of 2023, we are very pleased to introduce the winners of our inaugural Pharmacy Practice + Business Awards.

Migraine, a neurological condition that affects 25% of Canadian households, has been historically dismissed, underdiagnosed and undertreated. Until recently, there have been few new advances in medications used to manage the condition.